appropriately the development of new pharmaceuticals. Although physicians have an arsenal of drugs to treat conditions like high … narrowly tailored to achieve these goals. One major potential source of incentives has been almost completely absent from the … which Medicaid pays for drugs enables needy patients to access existing treatments, but it perversely decreases incentives …

How does a firm’s market power in existing products affect its incentives to innovate? We explore this fundamental … firms having reduced incentives to innovate when they are able to maintain their market power, highlighting a specific …